Phenotypic characterisation of immune cell infiltrates in testicular germ cell neoplasia

Journal of Reproductive Immunology

Volumn 100, Issue 2, 2013, Pages 135-145

  Hvarness, Tine ^a   Nielsen, John E ^a   Almstrup, Kristian ^a   Skakkebaek, Niels E ^a   Rajpert De Meyts, Ewa ^a   Claesson, Mogens H ^b  

^a Mental Health Center Glostrup   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Carcinoma in situ; Germ cell tumour; Immune cell infiltration; Immune privilege; Immune surveillance; Testis

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MALE INFERTILITY; PHENOTYPE; PRIORITY JOURNAL; SEMINOMA; SERTOLI CELL; SINGLE CELL ANALYSIS; T LYMPHOCYTE; TESTIS BIOPSY;

CARCINOMA IN SITU; GERM CELL TUMOUR; IMMUNE CELL INFILTRATION; IMMUNE PRIVILEGE; IMMUNE SURVEILLANCE; TESTIS;

ADULT; ANTIGENS, CD45; CARCINOMA IN SITU; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; SEMINOMA; TESTICULAR NEOPLASMS; TESTIS; YOUNG ADULT;

EID: 84889094690     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.10.005     Document Type: Article

References (55)

1. Almstrup K., Hoei-Hansen C.E., Wirkner U., et al. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res. 2004, 64:4736-4743.
2. Aubry F., Habasque C., Satie A.P., Jégou B., Samson M. Expression and regulation of the CXC-chemokines, GRO/KC and IP-10/mob-1 in rat seminiferous tubules. Eur. Cytokine Net. 2000, 11:690-698.
3. Baldini E., Ulisse S., Marchioni E., et al. Expression of Fas and Fas ligand in human testicular germ cell tumors. Int. J. Androl. 2009, 32:123-130.
4. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
5. Bansal-Pakala P., Halteman B.S., Cheng M.H-Y., Croft M. Costimulation of CD8 T cell responses by OX40. J. Immunol. 2004, 172:4821-4825.
6. Bell D.A., Flotte T.J., Bhan A.K. Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate. Hum. Pathol. 1987, 18:511-520.
7. Blomberg-Jensen M., Nielsen J.E., Jørgensen A., et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum. Reprod. 2010, 25:1303-1311.
8. Bols B., Jensen L., Jensen A., Braendstrup O. Immunopathology of in situ seminoma. Int. J. Exp. Pathol. 2000, 81:211-217.
9. Braendstrup O. HLA class I antigens are expressed by Sertoli cells of intratubular germ cell neoplasia. APMIS 1996, 104:579-582.
10. Braendstrup O., Møller M.L., Werdelin O. Sertoli cells of intratubular germ cell neoplasia express beta 2 microglobulin. APMIS 1995, 103:548-552.
11. Bui J.D., Schreiber R.D. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?. Curr. Opin. Immunol. 2007, 19(2):203-208.
12. Cao X. Regulatory T cells and immune tolerance to tumors. Immunol. Res. 2010, 46:79-93.
13. Donner J., Kliesch S., Brehm R., Bergmann M. From carcinoma in situ to testicular germ cell tumour. APMIS 2004, 112:79-88.
14. Duan Y.G., Yu C.F., Novak N., et al. Immunodeviation towards a Th17 immune response associated with testicular damage in azoospermic men. Int. J. Androl. 2011, 34:e536-e545.
15. Fijak M., Bhushan S., Meinhardt A. Immunoprivileged sites: the testis. Methods Mol. Biol. 2011, 677:459-470.
16. Fink C., Weigel R., Hembes T., Lauke-Wettwer H., Kliesch S., Bergmann M., Brehm R.H. Altered expression of ZO-1 and ZO-2 in Sertoli cells and loss of blood-testis barrier integrity in testicular carcinoma in situ. Neoplasia 2006, 8:1019-1027.
17. Galon J., Costes A., Sanchez-Cabo F., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313:1960-1964.
18. Gemmell E., Strutton G.M., Seymour G.J., et al. An immunohistopathological characterisation of mixed non-seminomatous germ cell tumors. Urol. Res. 1988, 16:13-17.
19. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
20. Head J.R., Neaves W.B., Billingham R.E. Immune privilege in the testis. I. Basic parameters of allograft survival. Transplantation 1983, 36:423-431.
21. Ioachim H.L. The stromal reaction of tumors: an expression of immune surveillance. J. Nat. Cancer Inst. 1976, 57:465-475.
22. Itoh M., Xie Q., Miyamoto K., Takeuchi Y. Major differences between the testis and epididymis in the induction of granulomas in response to extravasated germ cells. I. A light microscopical 2006; study in mice. Int. J. Androl. 1999, 22:316-323.
23. Jacobo P., Guazzone V.A., Jarazo-Dietrich S., Theas M.S., Lustig L. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis. J. Reprod. Immunol. 2009, 81:44-54.
24. Jensen S.M., Maston L.D., Gough M.J., et al. Signaling through OX40 enhances antitumor immunity. Semin. Oncol. 2010, 37:524-532.
25. Jørgensen N., Rajpert-De Meyts E., Graem N., et al. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab. Invest. 1995, 72:223-231.
26. Kersemaekers A-M.F., van Weeren P.C., Oosterhuis J.W., Looijenga L.H.J. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumors of the adult testis. J. Pathol. 2002, 196:423-429.
27. Kim H.J., Verbinnen B., Tang X., Lu L., Cantor H. Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature 2010, 467:328-332.
28. Klein B., Klein T., Konichezky M., et al. The expression of HLA class I antigens in germ cell testicular cancer. Am. J. Clin. Pathol. 1990, 93:202-207.
29. Kliesch S., Behre H.M., Hertle L., Bergmann M. Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes. J. Urol. 1998, 160:1894-1898.
30. Mostofi F.K., Sesterhenn I. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors. Natl. Cancer Inst. Monogr. 1978, 49:133-141.
31. Nakanoma T., Nakamura K., Deguchi N., et al. Immunohistological analysis of tumor infiltrating lymphocytes in seminoma using monoclonal antibodies. Virchows Arch. A Pathol. Anat. Histopathol. 1992, 421:409-413.
32. Nouri A.M., Hussain R.F., Oliver R.T., et al. Immunological paradox in testicular tumors: the presence of a large number of activated T-cells despite the complete absence of MHC antigens. Eur. J. Cancer 1993, 29A:1895-1899.
33. Oosterhuis J.W., Looijenga L.H.J. Testicular germ-cell tumors in a broader perspective. Nat. Rev. Cancer 2005, 5:210-222.
34. Page S.T., Plymate S.R., Bremner W.J., et al. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am. J. Physiol. Endocrinol. Metabol. 2006, 290:E856-E863.
35. Pagès F., Kirilovsky A., Mlecnik B., et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J. Clin. Oncol. 2009, 27:5944-5951.
36. Parker C., Milosevic M., Panzarella T., et al. The prognostic significance of the tumor infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance. Eur. J. Cancer 2002, 38:2014-2019.
37. Piersma S.J., Jordanova E.S., van Poelgeest M.I.E., et al. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res. 2007, 67:354-361.
38. Rajpert-De Meyts E., Bartkova J., Samson M., et al. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 2003, 111:267-278.
39. Raman D., Baugher P.J., Thu Y.M., Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007, 256:137-165.
40. Sato E., Olson S.H., Ahnm J., et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18538-18543.
41. Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
42. Schütte B., Holstein A.F., Schirren C. Macrophages lysing seminoma cells in patients with carcinoma-in-situ (CIS) of the testis. Andrologia 1988, 20:295-303.
43. Schweyer S., Soruri A., Baumhoer D., et al. Expression of CXC chemokine IP-10 in testicular germ cell tumors. J. Pathol. 2002, 197(1):89-97.
44. Skakkebaek N.E. Possible carcinoma-in-situ of the testis. Lancet 1972, 2:516-517.
45. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 2001, 16:972-978.
46. Sonne S.B., Almstrup K., Dalgaard M., et al. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res. 2009, 69:5241-5250.
47. Spiess A.-N., Feig C., Schulze W., et al. Cross-platform gene expression signature of human spermatogenic failure reveals inflammatory-like response. Hum. Reprod. 2007, 22:2936-2946.
48. Tarulli G.A., Stanton P.G., Loveland K.L., Rajpert-De Meyts E., McLachlan R.I., Meachem S.J. A survey of Sertoli cell differentiation in men after gonadotropin suppression and in testicular cancer. Spermatogenesis 2013, 3(1):e24014-e24017.
49. Teng M.W.L., Andrews D.M., McLaughlin N., et al. IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8328-8333.
50. Tomita Y., Kimura M., Tanikawa T., et al. Immunohistochemical detection of intercellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex class I antigens in seminoma. J. Urol. 1993, 149:659-663.
51. Torres A., Casanova J.F., Nistal M., Regadera J. Quantification of immunocompetent cells in testicular germ cell tumors. Histopathology 1997, 30:23-30.
52. Weinberg A.D., Vella A.T., Croft M. OX-40: life beyond the effector T cell stage. Semin. Immunol. 1998, 10:471-480.
53. Willis S.N., Mallozzi S.S., Rodig S.J., Cronk K.M., McArdel S.L., Caron T., Pinkus G.S., Lovato L., Shampain K.L., Anderson D.E., Anderson R.C., Bruce J.N., O'Connor K.C. The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response. J. Immunol. 2009, 182. 3310.17.
54. Yakirevich E., Lefel O., Sova Y., et al. Activated status of tumor-infiltrating lymphocytes and apoptosis in testicular seminoma. J. Pathol. 2002, 196:67-75.
55. Zaidi M.R., Davis S., Noonan F.P., et al. Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature 2011, 469:548-553.